Citigroup Inc Enanta Pharmaceuticals Inc Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Citigroup Inc holds 14,677 shares of ENTA stock, worth $137,083. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,677

Previous 4,558 222.01%

Holding current value

$137,083

Previous $59,000 157.63%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$10.05 - $16.54 $101,695 - $167,368	10,119 Added 222.01%	14,677 $152,000
Q2 2024 Aug 12, 2024	BUY	$11.43 - $17.02 $8,389 - $12,492	734 Added 19.19%	4,558 $59,000
Q1 2024 May 10, 2024	BUY	$10.08 - $17.46 $9,989 - $17,302	991 Added 34.98%	3,824 $66,000
Q4 2023 Feb 09, 2024	BUY	$8.18 - $10.78 $18,699 - $24,643	2,286 Added 417.92%	2,833 $26,000
Q3 2023 Nov 09, 2023	SELL	$11.09 - $22.13 $440,084 - $878,184	-39,683 Reduced 98.64%	547 $6,000
Q2 2023 Aug 10, 2023	SELL	$20.68 - $39.85 $210,729 - $406,071	-10,190 Reduced 20.21%	40,230 $860,000
Q1 2023 May 11, 2023	BUY	$38.82 - $54.59 $72,205 - $101,537	1,860 Added 3.83%	50,420 $2.04 Million
Q4 2022 Feb 09, 2023	SELL	$40.77 - $53.73 $882,018 - $1.16 Million	-21,634 Reduced 30.82%	48,560 $2.26 Million
Q3 2022 Nov 10, 2022	BUY	$48.29 - $71.27 $214,600 - $316,723	4,444 Added 6.76%	70,194 $3.64 Million
Q2 2022 Aug 10, 2022	BUY	$38.13 - $76.93 $1.42 Million - $2.87 Million	37,249 Added 130.69%	65,750 $3.11 Million
Q1 2022 May 12, 2022	SELL	$56.06 - $74.11 $1.39 Million - $1.84 Million	-24,797 Reduced 46.53%	28,501 $2.03 Million
Q4 2021 Feb 10, 2022	BUY	$60.19 - $97.37 $1.61 Million - $2.6 Million	26,691 Added 100.32%	53,298 $3.99 Million
Q3 2021 Nov 10, 2021	BUY	$41.02 - $58.65 $1.09 Million - $1.56 Million	26,607 New	26,607 $1.51 Million

Others Institutions Holding ENTA

# of Institutions

110

Shares Held

21.1M

Call Options Held

4.8K

Put Options Held

4.6K

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $194M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account